- Shoenfeld, Y. and Mozes, E. (1990) "Pathogenic idiotypes of autoantibodies in autoimmunity", FASEB J. 4, 2646 - 2651
- Kotzin, B.L. and O'Dell, J.R. (1995) "Systemic lupus erythematosus", In: Frank, M.M., Austen, K.F., Claman, H.N. and Unanue, E.R., eds, Samter's Immunologic Diseases (Little, Brown and Co., Boston), pp 667 - 697
- Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben Basat, M., Meshorer, A., Bakimer, R. and Mozes, E. (1988) "Induction of a systemic lupus erythematosus like disease in mice by a common human anti-DNA idiotype", Proc. Natl Acad. Sci. USA 85, 2260 - 2264
- Waisman, A., Mendelovic, S., Ruiz, J.P., Zinger, H., Meshorer, A. and Mozes, E. (1993) "The role of the 16/6 idiotype network in the induction and manifestation of systemic lupus erythematosus", Int. Immunol. 5, 1293 - 1300
- Waisman, A. and Mozes, E. (1993) "Variable regions of autoantibodies isolated from mice with experimental systemic lupus erythematosus", Eur. J. Immunol. 23, 1566 - 1573
- Waisman, A., Ruiz, J.P., Israeli, E., Eilat, E., Konen-Waisman, S., Zinger, H., Dayan, M. and Mozes, E. (1997) "Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody", Proc. Natl Acad. Sci. USA 94, 4620 - 4625
- Brosh, N., Zinger, H., Fridkin, M. and Mozes, E. (2000) "A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid substituted analogs", Cell Immunol. 205, 52 - 61
- Brosh, N., Eilat, E., Zinger, H. and Mozes, E. (2000) "Characterization and role in experimental SLE of T cell lines specific to peptides based on CDR1 and CDR3 of a pathogenic anti-DNA monoclonal antibody", Immunology 99, 257 - 265
- Brosh, N., Dayan, M., Fridkin, M. and Mozes, E. (2000) "A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is a dominant T cell epitope also in (NZBXNZW)F1 lupus-prone mice", Immunol. Lett. 72, 61 - 68
- Handwerger, B.S., Rus, V., da Silva, L. and Via, C.S. (1994) "The role of cytokines in the immunopathogenesis of lupus", Springer Semin. Immunopathol. 16, 153 - 180
- Horwitz, D.A. and Jacob, C.O. (1994) "The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications", Springer Semin. Immunopathol. 16, 181 - 200
- Theofilopoulos, A.N. and Lawson, B.R. (1999) "Tumor necrosis factor and other cytokines in murine lupus", Ann. Rheum. Dis. 58 (1), 149 - 155
- Segal, R., Bermas, B.L., Dayan, M., Kalush, F., Shearer, G.M. and Mozes, E. (1997) "Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease", J. Immunol. 158, 3009 - 3016
- Holdsworth, S.R., Kitching, A.R. and Tipping, P.G. (1999) "Th1 and Th2 T helper cell subsets affect patterns of injury and outcome in glomerulonephritis", Kidney Int. 55, 1198 - 1216
- Merrifield, R. (1986) "Solid phase synthesis", Science 232, 341 - 347
- Waisman, A., Shoenfeld, Y., Blank, M., Ruiz, P.J. and Mozes, E. (1995) "The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment", Int. Immunol. 7, 689 - 696
- Mao, C., Osman, G.E., Adams, S. and Datta, S.K. (1994) "T cell receptor alpha-chain § repertoire of pathogenic autoantibody-inducing T cells in lupus mice", J. Immunol. 152, 1462 - 1470
- Beverly, B., Kang, S.M., Lenardo, J. and Schwartz, R.H. (1992) "Reversal of in vitro T cell clonal anergy by IL-2 stimulation", Int. Immunol. 4, 661 - 671
- Gibert, K.M. and Weigle, W.O. (1993) "Th1 cell anergy and blockade in G1a phase of the cell cycle", J. Immunol. 151, 1245 - 1254
- Powell, J.D., Lerner, C.G. and Schartz, R.H. (1999) "Inhibition of cell cycle progression by Rapamycin induces T cell clonal anergy even in the presence of costimulation", J. Immunol. 162, 2775 - 2784
- Dean, G.S., Tyrrell-Price, J., Crawley, E. and Isenberg, D.A. (2000) "Cytokines and systemic lupus erythematosus", Ann. Rheum. Dis. 59, 243 - 251
- Horwitz, D.A., Wang, H. and Gray, J.D. (1994) "Cytokine gene profile in circulating blood mononuclear cells for patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA", Lupus 3, 423 - 428
- Viallard, J.F., Pellegrin, J.L., Ranchin, V., Schaaeverbeke, T., Dehais, J., Longy-Boursier, M., et al., (1999) "Th1 (IL-2, IFN-gamma) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)", Clin. Exp. Immunol. 115, 189 - 195
- Amital, H., Levi, Y., Blank, M., Barak, V., Langevitz, P., Afek, A., et al., (1998) "Immunomodulation of murine experimental SLE-like disease by interferon-gamma", Lupus 7, 445 - 454
- Haas, C., Ryffel, B. and Le Hir, M. (1997) "IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice", J. Immunol. 158, 5484 - 5491
- Peng, S.L.M.J. and Craft, J. (1997) "Roles of interferon-gamma and interleukin-4 in murine lupus", J. Clin. Investig. 99, 1936 - 1946
- Jacob, C.O., van der Meide, P.H. and McDevitt, H.O. (1987) "In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon", J. Exp. Med. 166, 798 - 803
- Ozmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B. and Garotta, G. (1995) "Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis", Eur. J. Immunol. 25, 6 - 12
- Davas, E.M., Tsirogianni, A., Kappou, I., Karamitsos, D., Economidou, I. and Dantis, P.C. (1999) "Serum IL-6, TNFalpha, p55 srTNFalpha, p75sr TNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus", Clin. Rheumatol. 18, 17 - 22
- Segal, R., Dayan, M., Zinger, H. and Mozes, E. (1995) "Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation", Clin. Exp. Immunol. 101, 66 - 72
- Dayan, M., Zinger, H., Kalush, F., Mor, G., Amir-Zaltzman, Y., Kohen, F., et al., (1997) "The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimentalsystemic lupus erythematosus are associated with cytokine modulations", Immunology 90, 101 - 108
- Segal, R., Dayan, M., Zinger, H. and Mozes, E. (2001) "Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFα monoclonal antibody and by pentoxiphyline", Lupus 10, 23 - 31
- Yaswen, L., Kulkarni, A.B., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., et al., (1996) "Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse", Blood 87, 1439 - 1445
- Ohtsuka, K., Gray, J.D., Stimmler, M.M., Toro, B. and Horwitz, D.A. (1998) "Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus", J. Immunol. 160, 2539 - 2545
- Kitamura, M., Suto, T., Yokoo, T., Shimizu, F. and Fine, L.G. (1996) "Transforming growth factor-beta is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesengial cells", J. Immunol. 156, 2964 - 2971
- Eilat, E., Zinger, H., Nyska, A. and Mozes, E. (2000) "Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody", J. Clin. Immunol. 20, 268 - 278
- Wloch, M.K., Alexander, A.L., Pippen, A.M.N., Pisetsky, D.S. and Gilkson, G.S. (1997) "Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA", J. Immunol. 158, 4500 - 4506
- Tillman, D., Nainn-Tsyr, J., Hill, R. and Marion, T. (1992) "Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZBxNZW)F1 mice", J. Exp. Med. 176, 761 - 779
- Jouanne, C., Avrameas, S. and Payelle-Brogard, B. (1999) "A peptide derived from a polyreactive monoclonal anti-DNA natural antibody can modulate lupus development in (NZBXNZW)F1 mice", Immunology 96, 333 - 339
- Kaliyaperumal, A., Michaels, M.A. and Datta, S.K. (1999) "Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells", J. Immunol. 162, 5775 - 5783
- Gaynor, B., Putterman, C., Valadon, P., Spatz, L., Scharff, M.D. and Diamond, B. (1997) "Peptide inhibition of glomerular deposition of an anti-DNA antibody", Proc. Natl Acad. Sci. USA 94, 1955 - 1960
- Singh, R.R., Ebling, F.M., Sercarz, E.E. and Hahn, B.H. (1995) "Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus", J. Clin. Investig. 96, 2990 - 2996
Treatment of Induced Murine SLE with a Peptide Based on the CDR3 of an Anti-DNA Antibody Reverses the Pattern of Pathogenic Cytokines
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.